CombiMatrix forms biothreat agents test deal:
This article was originally published in Clinica
CombiMatrix has linked up with Science Applications International to develop microarrays for identifying multiple biothreat organisms. Both companies have US Department of Defense (DoD) contracts supporting the development of complementary products. Leveraging these DoD funds can help expedite the development and testing of new identification and diagnostic assays for conventional biothreat agents and emerging and genetically engineered pathogens, said Mukilteo, Washington-based CombiMatrix. Under the collaboration, Science Applications' bioinformatics know-how will be combined with CombiMatrix' multiplexed microarray technology. CombiMatrix said that under the DoD contract, it was developing electrochemical detection as an alternative to the current use of large and expensive optical readers and dyes used in fluorescence detection.